Presentation is loading. Please wait.

Presentation is loading. Please wait.

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial 

Published byOsborn Parsons Modified over 6 years ago

Similar presentations

Presentation on theme: "Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial "— Presentation transcript:

1 Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial  Cynthia Rand, PhD, Andrew Bilderback, MS, Kathleen Schiller, PhD, Jonathan M. Edelman, MD, Carolyn M. Hustad, PhD, Robert S. Zeiger, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 119, Issue 4, Pages (April 2007) DOI: /j.jaci Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 MIAMI study design. Schematic showing the 3 periods of MIAMI. Continuous electronic monitoring of adherence took place during all 3 periods. Reprinted with permission from Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, et al. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. Am J Med 2005;118: Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Dose-response relationship between active treatment and study outcomes: DB. Line graphs showing the results of the regression analysis for change in FEV1 percent predicted (A) and change in percentage of asthma RFDs (%RFD) with adherence to fluticasone or montelukast (B) for patients with baseline FEV1 percent predicted ≤86%, >86%, and for all participants. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 Dose-response relationship between active treatment and study outcomes: OL. Line graphs showing the results of the regression analysis for change in FEV1 percent predicted (A) and change in percentage of asthma RFDs (%RFD) with adherence to fluticasone or montelukast (B) for patients with baseline FEV1 percent predicted ≤86%, >86%, and for all participants. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial "

Similar presentations

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
The Pediatric Asthma Control and Communication Instrument asthma questionnaire: For use in diverse children of all ages  Sande O. Okelo, MD, PhD, Michelle.

The Pediatric Asthma Control and Communication Instrument asthma questionnaire: For use in diverse children of all ages  Sande O. Okelo, MD, PhD, Michelle.
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Alveolar nitric oxide and asthma control in mild untreated asthma

Alveolar nitric oxide and asthma control in mild untreated asthma
The natural history of soy allergy

The natural history of soy allergy
Test for Respiratory and Asthma Control in Kids (TRACK): Clinically meaningful changes in score  Robert S. Zeiger, MD, PhD, Michael Mellon, MD, Bradley.

Test for Respiratory and Asthma Control in Kids (TRACK): Clinically meaningful changes in score  Robert S. Zeiger, MD, PhD, Michael Mellon, MD, Bradley.
Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD 

Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD 
Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations  Peter G. Gibson, MBBS(Hons),

Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations  Peter G. Gibson, MBBS(Hons),
Genetics and the variability of treatment response in asthma

Genetics and the variability of treatment response in asthma
Alalia Berry, MD, William W. Busse, MD 

Alalia Berry, MD, William W. Busse, MD 
A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma  L. Keoki Williams, MD, MPH,

A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma  L. Keoki Williams, MD, MPH,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Effect of montelukast for treatment of asthma in cigarette smokers

Effect of montelukast for treatment of asthma in cigarette smokers
Overcoming barriers to nonadherence in asthma treatment

Overcoming barriers to nonadherence in asthma treatment
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,

Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Inhaler reminders improve adherence with controller treatment in primary care patients with asthma  Juliet M. Foster, PhD, Tim Usherwood, BSc, MD, BS,

Inhaler reminders improve adherence with controller treatment in primary care patients with asthma  Juliet M. Foster, PhD, Tim Usherwood, BSc, MD, BS,
Badrul A. Chowdhury, MD, PhD 

Badrul A. Chowdhury, MD, PhD 

Similar presentations

Ads by Google